Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Neely Atkinson

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Biomedical Optics|July 7, 2007
Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probeJ Adrian Freeberg, Dan M Serachitopol, Nick McKinnon, et al.
Journal of Biomedical Optics|May 8, 2012
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settingsJose-Miguel Yamal, Getie A Zewdie, Dennis D Cox, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcomaRobin A Lacour, Elizabeth Euscher, E Neely Atkinson, et al.
Gynecologic Oncology|September 13, 2005
Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trialHeung Gon Kim, Jose-Miguel Yamal, Xiao-Chun Xu, et al.
Journal of Biomedical Optics|July 7, 2007
Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasiaBrian M Pikkula, Olga Shuhatovich, Roderick L Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancerZhen Lu, Robert Z Luo, Hongqi Peng, et al.
Cancer Research|May 1, 2002
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivoLin Ji, Masahiko Nishizaki, Boning Gao, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 casesBrian M Slomovitz, Thomas W Burke, Patricia J Eifel, et al.
Gynecologic Oncology|March 22, 2003
beta-catenin nuclear localization is associated with grade in ovarian serous carcinomaChristine M Lee, Hyun Shvartsman, Michael T Deavers, et al.
Cancer Gene Therapy|October 16, 2004
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivoIsao Ito, Lin Ji, Fumihiro Tanaka, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Biomedical Optics|July 7, 2007
Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probeJ Adrian Freeberg, Dan M Serachitopol, Nick McKinnon, et al.
Journal of Biomedical Optics|May 8, 2012
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settingsJose-Miguel Yamal, Getie A Zewdie, Dennis D Cox, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcomaRobin A Lacour, Elizabeth Euscher, E Neely Atkinson, et al.
Gynecologic Oncology|September 13, 2005
Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trialHeung Gon Kim, Jose-Miguel Yamal, Xiao-Chun Xu, et al.
Journal of Biomedical Optics|July 7, 2007
Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasiaBrian M Pikkula, Olga Shuhatovich, Roderick L Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancerZhen Lu, Robert Z Luo, Hongqi Peng, et al.
Cancer Research|May 1, 2002
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivoLin Ji, Masahiko Nishizaki, Boning Gao, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 casesBrian M Slomovitz, Thomas W Burke, Patricia J Eifel, et al.
Gynecologic Oncology|March 22, 2003
beta-catenin nuclear localization is associated with grade in ovarian serous carcinomaChristine M Lee, Hyun Shvartsman, Michael T Deavers, et al.
Cancer Gene Therapy|October 16, 2004
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivoIsao Ito, Lin Ji, Fumihiro Tanaka, et al.
Pageof 5